Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32979319.
- Also identified by DOI 10.1016/j.cell.2020.09.005 and PMC identifier 7470737.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The SARS-CoV-2 pandemic has posed a significant challenge for risk evaluation and mitigation among cancer patients. Susceptibility to and severity of COVID-19 in cancer patients has not been studied in a prospective and broadly applicable manner. CAPTURE is a pan-cancer, longitudinal immune profiling study designed to address this knowledge gap.
Medical subject headings
- Coronavirus Infections
- Monitoring, Immunologic
- Neoplasms
- Pneumonia, Viral